Stifel Nicolaus Cuts Xylem (NYSE:XYL) Price Target to $166.00

Xylem (NYSE:XYLGet Free Report) had its price target reduced by Stifel Nicolaus from $172.00 to $166.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the industrial products company’s stock. Stifel Nicolaus’ price objective points to a potential upside of 32.95% from the company’s previous close.

A number of other analysts have also recently weighed in on the company. Royal Bank of Canada lowered their price target on Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. TD Cowen lowered their price target on Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a research report on Wednesday, November 6th. UBS Group began coverage on Xylem in a research report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price target on the stock. Citigroup upgraded Xylem from a “neutral” rating to a “buy” rating and upped their price target for the company from $135.00 to $148.00 in a research report on Monday. Finally, Robert W. Baird decreased their target price on Xylem from $175.00 to $154.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and an average target price of $149.91.

Check Out Our Latest Analysis on XYL

Xylem Stock Performance

Shares of XYL traded down $3.71 on Wednesday, reaching $124.86. 535,507 shares of the stock traded hands, compared to its average volume of 1,231,819. The firm has a market cap of $30.33 billion, a price-to-earnings ratio of 36.57, a P/E/G ratio of 2.33 and a beta of 1.05. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.96 and a quick ratio of 1.42. Xylem has a 12 month low of $106.52 and a 12 month high of $146.08. The stock’s 50-day moving average price is $128.44 and its 200-day moving average price is $132.82.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The firm had revenue of $2.10 billion for the quarter, compared to analysts’ expectations of $2.17 billion. During the same period in the prior year, the business posted $0.99 earnings per share. The business’s revenue was up .2% compared to the same quarter last year. Equities analysts forecast that Xylem will post 4.23 EPS for the current fiscal year.

Hedge Funds Weigh In On Xylem

Large investors have recently made changes to their positions in the company. Charles Schwab Investment Management Inc. lifted its stake in shares of Xylem by 0.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,345,768 shares of the industrial products company’s stock valued at $181,719,000 after acquiring an additional 5,817 shares during the period. Victory Capital Management Inc. lifted its stake in Xylem by 9.3% in the third quarter. Victory Capital Management Inc. now owns 1,627,279 shares of the industrial products company’s stock valued at $219,731,000 after buying an additional 137,883 shares during the period. BNP Paribas Financial Markets lifted its stake in Xylem by 16.5% in the third quarter. BNP Paribas Financial Markets now owns 547,435 shares of the industrial products company’s stock valued at $73,920,000 after buying an additional 77,639 shares during the period. Groupama Asset Managment lifted its stake in Xylem by 89.6% in the third quarter. Groupama Asset Managment now owns 16,340 shares of the industrial products company’s stock valued at $2,206,000 after buying an additional 7,723 shares during the period. Finally, Cerity Partners LLC lifted its stake in Xylem by 22.9% in the third quarter. Cerity Partners LLC now owns 115,045 shares of the industrial products company’s stock valued at $15,534,000 after buying an additional 21,464 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Xylem

(Get Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.